Canaccord Genuity Group Issues Pessimistic Forecast for Palvella Therapeutics (NASDAQ:PVLA) Stock Price
Palvella Therapeutics (NASDAQ:PVLA – Free Report) had its price target trimmed by Canaccord Genuity Group from $53.00 to $52.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other equities research analysts have also issued reports on the company. TD Cowen started coverage […]
Palvella Therapeutics (NASDAQ:PVLA – Free Report) had its price target trimmed by Canaccord Genuity Group from $53.00 to $52.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Several other equities research analysts have also issued reports on the company. TD Cowen started coverage […]
